Suppr超能文献

CD30(Ber-H2)在未分化型鼻咽癌和淋巴上皮瘤样癌中的表达:与间变性大细胞淋巴瘤的比较研究

Expression of CD30 (Ber-H2) in nasopharyngeal carcinoma, undifferentiated type and lymphoepithelioma-like carcinoma. A comparison study with anaplastic large cell lymphoma.

作者信息

Kneile J R, Tan G, Suster S, Wakely P E

机构信息

Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA.

出版信息

Histopathology. 2006 Jun;48(7):855-61. doi: 10.1111/j.1365-2559.2006.02449.x.

Abstract

AIMS

Undifferentiated nasopharyngeal non-keratinizing carcinoma (UNPC), formerly known as lymphoepithelioma, frequently metastasizes at an early stage to regional lymph nodes and, thus, may be difficult to distinguish from Hodgkin's lymphoma (HL) or anaplastic large cell lymphoma (ALCL). CD30 expression is a useful diagnostic stain in both HL and ALCL, but its expression in UNPC deserves clarification. The aim of this study was to evaluate CD30 expression in UNPC and lymphoepithelioma-like carcinoma (LELC) from other anatomic locations and compare it with ALCL and squamous cell carcinoma (SCC).

METHODS AND RESULTS

CD30 immunoreactivity was examined in 38 cases of primary or metastatic UNPC, six cases of LELC, 10 cases of SCC and seven cases of ALCL. CD30 immunoreactivity was observed in four of 38 (10.5%) cases of UNPC. CD30 staining was absent in all cases of LELC (0/6) and SCC (0/10). All cases of ALCL (7/7) were strongly positive for CD30.

CONCLUSIONS

The majority of cases of UNPC are immunohistochemically negative for CD30; however, a small subset of cases expresses CD30 antigen. These findings provide additional evidence that CD30 expression is not restricted to neoplasms of lymphoid origin. This should be taken into consideration when interpreting CD30 immunohistology and the possibility of UNPC.

摘要

目的

未分化型鼻咽非角化性癌(UNPC),以前称为淋巴上皮瘤,常在早期转移至区域淋巴结,因此可能难以与霍奇金淋巴瘤(HL)或间变性大细胞淋巴瘤(ALCL)相区分。CD30表达在HL和ALCL中是一种有用的诊断性染色,但它在UNPC中的表达情况尚需阐明。本研究的目的是评估UNPC和来自其他解剖部位的淋巴上皮瘤样癌(LELC)中CD30的表达,并将其与ALCL和鳞状细胞癌(SCC)进行比较。

方法与结果

检测了38例原发性或转移性UNPC、6例LELC、10例SCC和7例ALCL中的CD30免疫反应性。在38例UNPC中有4例(10.5%)观察到CD30免疫反应性。所有LELC病例(0/6)和SCC病例(0/10)均未检测到CD30染色。所有ALCL病例(7/7)的CD30均呈强阳性。

结论

大多数UNPC病例免疫组化检测CD30呈阴性;然而,一小部分病例表达CD30抗原。这些发现提供了额外的证据,表明CD30表达并不局限于淋巴源性肿瘤。在解释CD30免疫组织学结果以及UNPC的可能性时应考虑到这一点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验